Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Charles A. Herzog, Eberhard Ritz(Heidelberg Engineering (Germany)), Patrick H. Pun(Duke University), Rod Passman(Northwestern University), Richard Asinger(University of Minnesota), Javier Dı́ez(Instituto de Salud Carlos III), Peter A. McCullough(Parkland Foundation), Stephanie DeLoach(Jefferson College), Robert G. Hart(University of British Columbia), Bertram L. Kasiske(University of Minnesota), David M. Charytan(NYU Langone Health), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Alan K. Berger(University of Minnesota System)
Cited by 925
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
|Circulation|2003|3.8k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
|New England Journal of Medicine|2006|2.1k